eprintid: 10189080
rev_number: 11
eprint_status: archive
userid: 699
dir: disk0/10/18/90/80
datestamp: 2024-03-15 10:20:32
lastmod: 2024-05-13 13:05:43
status_changed: 2024-03-15 10:20:32
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Giganti, Francesco
creators_name: Gupta, Rajan T
title: Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA?
ispublished: inpress
divisions: UCL
divisions: B02
divisions: C10
divisions: D16
keywords: cost effectiveness, multiparametric prostate MRI, Prostate cancer
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
date: 2024-02-14
date_type: published
publisher: American Roentgen Ray Society
official_url: http://dx.doi.org/10.2214/ajr.24.30973
full_text_type: other
language: eng
verified: verified_manual
elements_id: 2248141
doi: 10.2214/AJR.24.30973
medium: Print-Electronic
lyricists_name: Giganti, Francesco
lyricists_id: FGIGA51
actors_name: Giganti, Francesco
actors_id: FGIGA51
actors_role: owner
full_text_status: restricted
publication: American Journal of Roentgenology
event_location: United States
issn: 0361-803X
citation:        Giganti, Francesco;    Gupta, Rajan T;      (2024)    Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA?                   American Journal of Roentgenology        10.2214/AJR.24.30973 <https://doi.org/10.2214/AJR.24.30973>.    (In press).   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10189080/1/giganti-gupta-2024-beyond-the-ajr-can-prostate-mri-and-mri-guided-biopsy-be-cost-effective-in-the-united-states-in.pdf